Ramasastry Saira 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
Ramasastry Saira
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-15$23.51/sh+2,000$47,020→ 2,000 total - Sale
Common Stock
[F1]2026-01-15$90.99/sh−2,000$181,980→ 0 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2026-01-15−2,000→ 8,000 totalExercise: $23.51Exp: 2032-06-01→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
- [F2]The stock option is fully vested.
Signature
/s/ Judit Ryvkin, Attorney-in-Fact|2026-01-15